Valuation Eurofins Scientific SE

Stocks

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-06-29 EDT			5-day change	1st Jan Change
68.18 ^EUR	-1.13%		+7.40%	+9.26%

06-04	Eurofins Scientific SE acquired High North Laboratories.	CI
05-14	Eurofins Scientific SE Develops And Offers New Solutions For Hantavirus Detection	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	20,893	12,900	11,336	9,273	11,036	11,915	-	-
Change	-	-38.26%	-12.13%	-18.2%	19.02%	7.96%	-	-
Enterprise Value (EV) ¹	23,132	15,739	14,041	12,269	14,677	15,357	14,999	14,629
Change	-	-31.96%	-10.79%	-12.62%	19.63%	4.63%	-2.33%	-2.47%
P/E	27.8x	22.2x	45.4x	26.9x	28x	23.7x	18.2x	15.2x
PBR	4.49x	2.7x	2.24x	1.73x	2.56x	2.48x	2.24x	2.04x
PEG	-	-1x	-0.8x	0.7x	1.3x	0.8x	0.6x	0.8x
Capitalization / Revenue	3.11x	1.92x	1.74x	1.33x	1.51x	1.57x	1.48x	1.37x
EV / Revenue	3.44x	2.34x	2.16x	1.77x	2.01x	2.02x	1.86x	1.69x
EV / EBITDA	12.2x	10.4x	10.3x	7.91x	8.94x	8.88x	7.91x	7.04x
EV / EBIT	15.7x	15.2x	16.7x	12.1x	13.6x	14x	12.1x	10.5x
EV / FCF	22.8x	23.2x	29.6x	15.3x	16.7x	21.3x	17x	15.1x
FCF Yield	4.39%	4.3%	3.38%	6.53%	5.97%	4.69%	5.87%	6.63%
Dividend per Share ²	1	1	0.5	0.5	0.72	0.7704	0.8987	0.9605
Rate of return	0.92%	1.49%	0.85%	1.01%	1.15%	1.13%	1.32%	1.41%
EPS ²	3.91	3.02	1.3	1.83	2.23	2.88	3.75	4.473
Distribution rate	25.6%	33.1%	38.5%	27.3%	32.3%	26.8%	24%	21.5%
Net sales ¹	6,718	6,712	6,515	6,951	7,296	7,600	8,074	8,666
EBITDA ¹	1,902	1,513	1,364	1,552	1,641	1,729	1,896	2,078
EBIT ¹	1,473	1,037	842	1,017	1,079	1,093	1,240	1,392
Net income ¹	783	606	310	406	475	516.7	676.2	795.9
Net Debt ¹	2,239	2,839	2,705	2,996	3,641	3,442	3,085	2,714
Reference price ²	108.80	67.06	58.98	49.31	62.40	68.18	68.18	68.18
Nbr of stocks (in thousands)	192,035	192,365	192,194	188,049	176,864	174,751	-	-
Announcement Date	2/22/22	3/1/23	2/27/24	1/30/25	1/29/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
EUROFINS SCIENTIFIC SE	23.95x	2.04x	8.96x	1.12%	13.74B
LONZA GROUP AG	32.21x	5.68x	17.59x	1.02%	46.2B
REVOLUTION MEDICINES, INC.	-22.9x	343.72x	-21.86x	-.--%	38.71B
IQVIA HOLDINGS INC.	23.26x	2.64x	11.39x	-.--%	31.9B
BEONE MEDICINES AG	41.76x	4.18x	26.75x	-.--%	31.12B
CELLTRION, INC.	27.93x	7.24x	18.62x	0.45%	23.77B
MEDPACE HOLDINGS, INC.	30.92x	5x	22.8x	-.--%	15.05B
IONIS PHARMACEUTICALS, INC.	-22.52x	14.77x	-22.09x	-.--%	13.42B
ICON PUBLIC LIMITED COMPANY	24.04x	1.91x	11.59x	-.--%	13.01B
Average	17.63x	43.02x	8.19x	0.29%	25.21B
Weighted average by Cap.	18.12x	62.93x	8.49x	0.32%